Comparison of microparticle enzyme and fluorescence polarization immunoassays in pediatric patients not receiving Digoxin

Therapeutic Drug Monitoring

Volumn 20, Issue 3, 1998, Pages 347-351

  Chicella, Michael ^a,b   Branim, Bill ^b   Lee, Kelley R ^a,b   Phelps, Stephanie J ^a,b,c  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b LE BONHEUR CHILDREN S HOSPITAL   (United States)

^c Department of Clinical Pharmacy ^*  (United States)

Author keywords

Digoxin; Digoxin like immunoreactive substances; Fluorescence polarization immunoassay; Microparticle enzyme immunoassay

Indexed keywords

BILIRUBIN; CREATININE; DIGITALIS LIKE FACTOR; DIGOXIN;

ADOLESCENT; ARTICLE; CHILD; CREATININE BLOOD LEVEL; CROSS REACTION; DIGOXIN BLOOD LEVEL; FEMALE; FLUORESCENCE POLARIZATION IMMUNOASSAY; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MICROPARTICLE ENZYME IMMUNOASSAY; NEWBORN; PRIORITY JOURNAL;

ADOLESCENT; CARDIOTONIC AGENTS; CHILD; CHILD, PRESCHOOL; CROSS REACTIONS; DIGOXIN; DRUG MONITORING; FEMALE; FLUOROIMMUNOASSAY; HUMANS; IMMUNOENZYME TECHNIQUES; INFANT; INFANT, NEWBORN; MALE; SENSITIVITY AND SPECIFICITY;

EID: 0031810663     PISSN: 01634356     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007691-199806000-00018     Document Type: Article

References (27)

1. Ebara H, Suzuki S, Nagashima K, et al. Digoxin- and digitoxin-like immunoreactive substances in amniotic fluid, cord blood, and serum of neonates. Pediatr Res 1986;20:28-31.
2. Besch HR, Huffered S, Lake M, Hurwitz R, Watanabe AM. False elevations of apparent digoxin levels in plasma of premature infants. Clin Chem 1976;22:1168.
3. Pudek MR, Seccombe DW, Whitfield MF, Ling E. Digoxin-like immunoreactivity in premature and full-term infants not receiving digoxin therapy. N Engl J Med 1983;308:904-5.
4. Pudek MR, Seccombe DW, Jacobesen BE, Whitfield MF. Seven different immunoassay kit comparison with respect to interference by a digoxin-like immunoreactive substance in serum from premature and full term infants. Clin Chem 1983;1972-3.
5. Valdes R, Graves SW, Brown BA, Landt M. Endogenous substance in newborn infants causing false positive digoxin measurements. J Pediatr 1983;102:947-50.
6. Koren G, Farine D, Maresky D, et al. Significance of the endogenous digoxin-like substance in infants and mothers. Clin Pharmacol Ther 1984;36:759-64.
7. Phelps SJ, Kamper CA, Bottorff MB, Sibai B. Effects of age and serum creatinine on endogenous digoxin-like substances in neonates, infants, and children. J Pediatr 1987;110:136-9.
8. Shimabukuro N, Ebara H, Maruyama K, Tomizawa S, Kuroume T. Determination of the presence of digoxin-like immunoreactive substance (DLIS) in the serum and urine in children with nephrotic syndrome. Clin Nephrol 1988;5:244-7.
9. Gruber KA, Whitaker JM, Buckalew VM Jr. Endogenous digitalislike substance in plasma of volume-expanded dogs. Nature 1980; 287:743-5.
10. Hamyln JM, Levinson PD, Ringel R, et al. Relationships among endogenous digitalis-like factors in essential hypertension. Federation Proc 1985;44:2782-8.
11. Hamyln JM, Ringel R, Schaeffer J, et al. A circulating inhibitor of (Na++ K+) ATPase associated with essential hypertension. Nature 1982;300:650-2.
12. Graves SW, Brown N, Valdes R. An endogenous digoxin-like substance in patients with renal impairment. Ann Intern Med 1983; 99:604-8.
13. Craver JL, Valdes R Jr. Anomalous serum digoxin concentrations in uremia. Ann Intern Med 1983;98:483-4.
14. Greenway DC, Nanji AA. Falsely increased results for digoxin in sera from patients with liver disease: Ten immunoassay kits compared. Clin Chem 1985;31:1078-9.
15. Gault MH, Vasdev SC, Longerich LL. Endogenous digoxin-like substance(s) and combined hepatic and renal failure. Ann Intern Med 1984;101:567-8.
16. Shilo L, Adawi A, Solomon G, et al. Endogenous digoxin-like immunoreactivity in congestive heart failure. Br Med J 1987;295: 415-6.
17. Barsano S, Shilo L, Bruderman I, et al. Endogenous digoxin-like immunoreactive factor is elevated in advanced chronic respiratory failure. Chest 1992;101:146-9.
18. Graves SW, Valdes R, Brown BA, Knight AB, Craig HR. Endogenous digoxin-immunoreactive substance in human pregnancies. J Clin Endocrinol Metab 1984;58:748-51.
19. Phelps SJ, Cochran EB, Gonzalez-Ruiz A, Tolley EA, Sabai B. The influence of gestational age and preeclampsia on the presence and magnitude of serum endogenous digoxin-like immunoreactive substance(s). Am J Obstet Gynecol 1988;158:34-9.
20. Gault MH, Vasdev S, Longerich L. Higher values for digitalis like factors with TDx Digoxin II. Clin Chem 1986;32:2000-1.
21. Avendano C, Alvarez S, Sacristan JA, Adin J, Alsar MJ. Interference of digoxin like immunoreactive substances with TDx digoxin II assay in different patients. Ther Drug Monit 1991;13:523-7.
22. Frye R, Mathews SE. Effects of digoxin like immunoreactive factor on the TDx digoxin II assay. Clin Chem 1987;33:629-30.
23. Jiang F, Wilhite TR, Smith CH, Landt M. A new digoxin immunoassay substantially free of interference by digoxin immunoreactive factor. Ther Drug Monit 1995;17:184-8.
24. Lacarelle B, Durand A, Labadie N, Cano JP. Comparison of digoxin like immunoreactive substance cross reactivity with two digoxin automated immunoassays. Ther Drug Monit 1989;11: 725-7.
25. Dodds HM, Norris RLG, Johnson AG, Pond SM. Evaluation and comparison of the TDx II, Stratus, and OPUS digoxin assays. Ther Drug Monit 1995;17:68-74.
26. Clerico A, Ghione S, Balzan S, Del Chicca MG. Digoxin-like immunoreactive substance: non-specific interference or a new hormone? J Nucl Med All Sci 1984;28:297-301.
27. Gervais A, Nanji AA, Greenway DC, McLean W. Digoxin-like immunoreactive substance (DLIS) in liver disease: Comparison of clinical and laboratory parameters in patients with and without dialysis. Drug Intel Clin Pharm 1987;21:450-2.cv